---

1.媒體來源:
Bloomberg彭博

2.記者署名:
Iain Marlow,?Sudhi Ranjan Sen, and?James Paton

3.完整新聞標題:
World Turns to China for Vaccines After India, U.S. Stumble
在印度和美國受挫后，世界開始轉向中國疫苗

4.完整新聞內文:
The world is fast becoming ever more reliant on China for vaccines, with Ind
ia’s raging virus outbreak stifling its ability to deliver on supply deals,
 even as the U.S. tries to position itself as a champion of wider access.
世界正越來越依賴中國的疫苗，印度肆虐的病毒爆發扼殺了其履行供應協議的能力，同
時盡管美國試圖將自己定位為更廣泛獲取疫苗的倡導者。

Over the past few weeks, leaders of some of the globe’s most populous natio
ns have sought more shots from China despite concerns about their effectiven
ess. Demand is expected to rise even further now that the World Health Organ
ization has?authorized?a vaccine from China’s?Sinopharm Group Co. Ltd.?and
is expected to soon do the same for?Sinovac Biotech Ltd.’s. That will allow
 developing countries in Asia, Africa and Latin America to access them throu
gh Covax, the global vaccination effort.


“China has become not just the largest exporter,” said?Yanzhong Huang, a C
hina specialist and senior fellow for global health at the Council on Foreig
n Relations. “In many countries it has become the only option.”
“中國已經不僅僅是最大的疫苗出口國，在許多國家，中國已成為唯一的選擇。”中國
問題專家、（美國）外交關系委員會全球衛生高級研究員Yanzhong Huang說

China’s reliability as a vaccine supplier is increasing its geopolitical cl
out at a time when the U.S. and the EU have been slow confronting the global
 pandemic as Covid hot spots rage out of control in India, Brazil and elsewh
ere. Compounding the difficulties, India’s crisis has dried up vaccine supp
lies and prompted many countries to turn toward China. Amid this backdrop, t
he U.S., for months preoccupied with its domestic vaccination push, has come
 under intense criticism for hoarding shots at the expense of a global respo
nse.


President Joe Biden made it clear this week that the U.S. intends to start p
laying a more active role. On Wednesday, the U.S. threw its weight behind a
movement to waive patents on Covid-19 vaccines to allow other countries to m
anufacture them. He’s vowing that the U.S. will become an “arsenal for fig
hting Covid-19” globally as outbreaks elsewhere in the world risk spawning
dangerous variants that could prolong the crisis. The administration’s effo
rts so far include plans to give away 60 million doses of?AstraZeneca Plc’s
 shot and to ramp up production of doses made by?Moderna Inc.,?Pfizer Inc.?a
nd?Johnson & Johnson.


In the meantime, countries from Uruguay to Senegal to Indonesia have few pla
ces to turn apart from Beijing -- and China is making the most of it.
與此同時，從烏拉圭到塞內加爾再到印度尼西亞，除了北京，幾乎沒有其他任何選擇，
而中國正充分利用這一機會。

The country has already shipped out about 240 million doses, more than all o
ther nations combined, and has committed to providing another 500 million, a
ccording to?Airfinity Ltd., a science information and analytics company. Ind
ia, the world’s third-biggest supplier after China and the European Union,
had exported 67 million doses to nearly 100 countries until the devastating
Covid-19 outbreak prompted it to halt most deliveries in recent weeks.



Access to the shots will provide a boost to the WHO-backed Covax effort, whi
ch relied heavily on the Serum Institute of India before the clampdown on ex
ports.
獲得這些疫苗將促進世衛組織支持的Covax努力，在印度限制出口之前，Covax在很大程
度上依賴于印度血清研究所（Serum Institute of India）。


Covax has shipped more than 50 million doses to 121 countries and territorie
s, well short of its goal and just a fifth of what the U.S. has administered
 domestically. A new pact with?Moderna?has expanded Covax’s portfolio, but
only a fraction of the 500 million doses it pledged will be available this y
ear.



WHO authorization of Chinese vaccines could make an immediate difference for
 governments waiting for that stamp of approval before giving them to citize
ns. Sri Lanka, for instance, has so far used less than 1% of its 600,000 Sin
opharm shots on foreign Chinese workers.


Some experts, though, are worried about the potential public-health impact o
f widely deploying Chinese vaccines that have demonstrated lower efficacy ra
tes than those made Pfizer and Moderna. And Chinese shots have already been
hampered by a lack of trial data and a preference for vaccines from the West
ern companies.


“The WHO approval of Chinese vaccines will, in the medium term, help to str
engthen Chinese power and authority within the region,” said?Nicholas Thoma
s, an associate professor at the City University of Hong Kong and editor of
several books on global health and foreign policy. “However, the low effica
cy rate of the Chinese vaccines means that this is an easily contestable pos
ition if the Western countries can ramp up their own supplies.”



That’s all the more reason for China to seize the moment while it can. Fore
ign Minister Wang Yi vowed last week that China would provide vaccines to co
untries that had been dependent on India during a?call?with counterparts fro
m South Asian nations.
這正是中國抓住時機的理由。外交部長王毅上周承諾，中國將向在危機中依賴印度疫苗
的國家提供疫苗，承諾將與南亞國家的同行。

On the same day, Chinese Defense Minister Wei Fenghe spoke with Bangladesh a
bout military cooperation. The country later approved emergency use of the S
inopharm shot after the bulk of 15 million doses it paid for from the Serum
Institute failed to arrive.
同日，中國國防部長魏鳳和與孟加拉國就軍事合作問題進行了會談。孟加拉國后來批準
緊急使用國藥集團的疫苗，因為它從印度血清研究所購買的1500萬劑疫苗未能送達。


Last month Chinese President Xi Jinping vowed to oppose “vaccine nationalis
m” in a call with Indonesia leader Joko Widodo, whose government green-lit
Sinopharm for emergencies soon afterward. Indonesia also secured as many as
15 million more shots of Sinovac.
上個月，中國習近平主席誓言反對“疫苗民族主義”，在印度尼西亞領導人佐科· 維多
多的呼吁下，印尼政府迅速對國藥疫苗開了綠燈。印尼獲得了多達1500萬劑的疫苗。

“In plain view, India’s export ban has made Indonesia increasingly depende
nt on vaccine supplies from China,” said Pandu Riono, an epidemiologist at
the University of Indonesia.
印尼大學流行病學家潘杜里奧諾說：“顯而易見，印度的出口禁令使印尼越來越依賴中
國的疫苗供應。

Other countries have had to play nice with China on geopolitical spats.
其他國家不得不在地緣政治爭端上與中國友好相處。

India’s export delays deprived the Philippines of its biggest vaccine order
 at a time it’s sparring with China over a territorial dispute. President R
odrigo Duterte rebuked his top diplomat this week for an expletive-laced twe
et denouncing Beijing over the spat while his government negotiates with Sin
ovac for a monthly delivery of as many as 4 million doses.


“China remains our benefactor,” Duterte said. “Just because we have a con
flict with China doesn’t mean to say that we have to be rude and disrespect
ful.”
杜特爾特說：“中國仍然是我們的恩人。”雖然我們與中國發生沖突，并不意味著我們
必須粗魯無禮。”

Some countries relying on Chinese vaccines such as Chile have moved relative
ly swiftly. However, worries persist about their potency: A Chilean governme
nt study found in April that Sinovac’s vaccine is?67% effective?in preventi
ng symptomatic Covid-19 infections and wards off 80% of fatalities. In Israe
l, meanwhile, Pfizer’s mRNA shot was?found?to be 92% effective in preventin
g symptomatic Covid-19 infections and 99% effective at preventing deaths --
though it’s harder to transport and must be stored at ultralow temperatures
.


India is confident it can ramp up supplies again in a few months once the cu
rrent outbreak is contained, according to a Foreign Ministry official in New
 Delhi who asked not to be identified. The government sees China trying to e
xploit India’s crisis but is confident that other countries understand its
predicament, the official added.


“The shipments are being repurposed for domestic purposes given the demand,
” said Indian Foreign Ministry spokesman Arindam Bagchi. “We have already
stated that our external supplies would be done keeping in mind our domestic
 requirements.”
印度外交部發言人巴吉（Arindam Bagchi）說：“鑒于需求，這些疫苗正被重新用于國
內用途。”我們已經說過，我們的外部供應將考慮到我們的國內需求。”

Meanwhile, from Pakistan to Brazil and Africa, many ordinary people have exp
ressed a lack of confidence in Chinese vaccines. In some areas of Africa, wh
ich is using shots from the U.S., India, Russia and China, skepticism on vac
cines mirrors that in parts of the developed world.



“We are being told that these vaccines are meant to get rid of Africans, so
 for now I will watch and observe those that have been inoculated,” said Pa
ssmore Mwanza, a 29-year-old worker in Zimbabwe. “I don’t want to be part
of an experiment of an outcome I don’t know.”


5.完整新聞連結 (或短網址):
https://tinyurl.com/4mtkfjhv

6.備註:
前段時間記得好多吱吱說中國疫苗在世界上沒人信，除了中國沒人會要中國疫苗。

這不，打臉來了，中國疫苗已經成為了世界上出口量最大的疫苗、超過其他國家出口疫苗
的總和。

我就想問一下綠腦吱們，臉疼不疼XDDDDD

--
--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 36.5.239.178 (中國)
※ 文章代碼(AID): #1WcqZD3P (Gossiping)
※ 文章網址: https://www.ptt.cc/bbs/Gossiping/M.1620789453.A.0D9.html